Biohaven Ltd.
NYSEBiohaven Ltd. reported earnings on August 11 and the short-covering trend that defined the pre-earnings setup has accelerated, yet the fundamental debate over BHV-7000's path to approval remains very much alive. The most consequential development since the pre-earnings note is a sharp single-day drop in short interest. Bears cut positions by nearly 6% on August 11 alone, bringing…
Snapshot as of 26 Aug 2026
Biohaven Ltd. reported earnings on August 11 and the short-covering trend that defined the pre-earnings setup has accelerated, yet the fundamental debate over BHV-7000's path to approval remains very much alive. The…
Biohaven Ltd. heads into tonight's earnings report with short sellers visibly retreating but the broader debate over BHV-7000's clinical future unresolved. The most striking feature of the setup is how far short…
Biohaven Ltd. is navigating an uncomfortable split: the stock has rallied 20% in a week, yet short sellers are not backing down. Short interest is deeply entrenched. At 20.5% of the free float — up from around 19% at…
Biohaven enters mid-May with a familiar problem: a lot of people are betting against it, and that number keeps growing. Short interest has climbed to just over 20% of the free float — roughly 25 million shares — and…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BHVN — free to start on ORTEX.
Sign up for free →Open BHVN on ORTEX